These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23201270)

  • 1. Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer.
    Zhang C; Awasthi N; Schwarz MA; Schwarz RE
    J Surg Res; 2013 Jun; 182(2):227-34. PubMed ID: 23201270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice.
    Ninomiya S; Inomata M; Tajima M; Ali AT; Ueda Y; Shiraishi N; Kitano S
    J Surg Res; 2009 Jun; 154(2):196-202. PubMed ID: 19329124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer.
    Yonemura Y; Endou Y; Bando E; Kuno K; Kawamura T; Kimura M; Shimada T; Miyamoto K; Sasaki T; Sugarbaker PH
    Cancer Lett; 2004 Jul; 210(2):189-96. PubMed ID: 15183534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
    Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
    Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
    Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
    In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
    Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
    Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.
    Matsui Y; Inomata M; Tojigamori M; Sonoda K; Shiraishi N; Kitano S
    Int J Oncol; 2005 Sep; 27(3):681-5. PubMed ID: 16077916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer.
    Bae WK; Park MS; Lee JH; Hwang JE; Shim HJ; Cho SH; Kim DE; Ko HM; Cho CS; Park IK; Chung IJ
    Biomaterials; 2013 Jan; 34(4):1433-41. PubMed ID: 23174142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-VEGF therapy for peritoneal dissemination model of gastric cancer considering of pharmacokinetics].
    Yagi Y; Fushida S; Fujita H; Kinami S; Ninomiya I; Fujimura T; Kayahara M; Ohta T; Yashiro M; Hirakawa K
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2005-8. PubMed ID: 19106505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
    Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Miyagi Y; Morinaga S; Noguchi Y; Yamamoto Y
    Hepatogastroenterology; 2006; 53(72):964-7. PubMed ID: 17153464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TS-1 on peritoneal dissemination of gastric cancer in nude mice.
    Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A
    Hepatogastroenterology; 2004; 51(59):1554-7. PubMed ID: 15362800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
    Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
    Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma.
    Hassan MS; Awasthi N; Li J; Schwarz MA; Schwarz RE; von Holzen U
    PLoS One; 2017; 12(2):e0171824. PubMed ID: 28225784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer].
    Bai FH; Yang L; Ji Q; Zhang YQ; Liu ZX; Wang ZZ; Yan L; Wang JB; Jin HF; Li TT
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3260-3. PubMed ID: 17313805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
    Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Ninomiya I; Ohta T
    BMC Cancer; 2017 Jan; 17(1):23. PubMed ID: 28056854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
    Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
    Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment results of peritoneal dissemination from gastric cancer by neoadjuvant intraperitoneal-systemic chemotherapy].
    Yonemura Y; Kawamura T; Bando E; Takahashi S; Sawa T; Yoshimitsu Y; Obata T; Endo Y; Sasaki T; Sugarbaker PH
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1723-6. PubMed ID: 15553695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
    Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
    Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers.
    Miura S; Endo Y; Yoshimura Y; Endo M; Yonemura Y; Sasaki T
    Oncol Rep; 2002; 9(6):1319-22. PubMed ID: 12375041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.